Gene content    
BRAF ( by HUGO)
V-Raf Murine Sarcoma Viral Oncogene Homolog B
Oncogene
V-Raf Murine Sarcoma Viral Oncogene Homolog B
V-Raf Murine Sarcoma Viral Oncogene Homolog B1
Proto-Oncogene B-Raf
BRAF1
RAFB1
NS7
94 KDa B-Raf Protein
B-RAF1
B-Raf Proto-Oncogene Serine/Threonine-Protein Kinase (P94)
Murine Sarcoma Viral (V-Raf) Oncogene Homolog B1
Serine/Threonine-Protein Kinase B-Raf
EC 2.7.11.1
p94
NCBI: 7q34    Ensembl: 7q34
BRAF_HUMANSize: 766 amino acidsMass: 84437 Da

  • Subunit: Monomer. Homodimer. Heterodimerizes with RAF1, and the heterodimer possesses a highly increased kinase activity compared to the respective homodimers or monomers. Heterodimerization is mitogen-regulated and enhanced by 14-3-3 proteins. MAPK1/ERK2 activation can induce a negative feedback that promotes the dissociation of the heterodimer by phosphorylating BRAF at Thr-753. Found in a complex with at least BRAF, HRAS, MAP2K1, MAPK3 and RGS14. Interacts with RIT1. Interacts (via N-terminus) with RGS14 (via RBD domains); the interaction mediates the formation of a ternary complex with RAF1, a ternary complex inhibited by GNAI1 (By similarity). Interacts with DGKH. Interacts with PRMT5. Interacts with KSR2 Sequence caution: Sequence=AAD43193.1; Type=Erroneous gene model prediction; Sequence=CAQ43111.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAQ43112.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAQ43113.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAQ43114.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAQ43115.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Sequence=CAQ43116.1; Type=Erroneous initiation; Note=Translation N-terminally shortened; Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for BRAF (see all 35): 1UWH (3D) [IMAGE] 1UWJ (3D) [IMAGE] 2FB8 (3D) [IMAGE] 2L05 (3D) [IMAGE] 3C4C (3D) [IMAGE] 3D4Q (3D) [IMAGE]
  • Tissue specificity: Brain and testis [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including BRAF (see all 7): Lung Cancer in human mouse rat Insulin Signaling Pathway in human mouse rat EGF / PDGF Signaling Pathway in human mouse rat Focal Adhesions in human mou
  • Function:
    Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron. Phosphorylates MAP2K1, and thereby contributes to the MAP kinase signal transduction pathway
                          
    Protein kinase involved in the transduction of mitogenic signals from the cell membrane to the nucleus. May play a role in the postsynaptic responses of hippocampal neuron. Phosphorylates MAP2K1, and thereby contributes to the MAP kinase signal transduction pathway
  • Catalytic activity:
    ATP + a protein = ADP + a phosphoprotein
  • Similarity:
    Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. RAF subfamily
                          
    Contains 1 phorbol-ester/DAG-type zinc finger
                          
    Contains 1 protein kinase domain
                          
    Contains 1 RBD (Ras-binding) domain [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000719Prot_kinase_domProtein kinaseDomain
    IPR001245Ser-Thr/Tyr_kinase_cat_domTyrosine protein kinaseDomain
    IPR002219Prot_Kinase_C-like_PE/DAG-bdProtein kinase C, phorbol ester/diacylglycerol bindingDomain
    IPR003116Raf-like_ras-bdRaf-like Ras-bindingDomain
    IPR008271Ser/Thr_kinase_ASSerine/threonine protein kinase, active siteActive Sites
    IPR011009Kinase-like_domProtein kinase-likeDomain
    BlocksIPB002219Protein kinase CProtein kinase C, phorbol ester/diacylglycerol binding
    IPB003116Raf-like Ras-bindingRaf-like Ras-binding

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process cellular response to calcium ion IDA GOA 18567582
    negative regulation of apoptotic process IDA GOA 19667065
    organ morphogenesis TAS GOA 9207797
    positive regulation of peptidyl-serine phosphorylation IDA GOA 19667065
    protein phosphorylation IDA GOA 17563371
    Molecular Function calcium ion binding IDA GOA 18567582
    identical protein binding IPI GOA 16858395
    NOT small GTPase binding IPI GOA 12194967
    protein binding IPI GOA 12620389
    protein kinase activity IDA GOA 17563371
    protein serine/threonine kinase activity IDA GOA 19667065

    Disorder & Mutation    
    Source Disease
    SWISS-PROTColorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. Note=The disease may be caused by mutations affecting the gene represented in this entry
    SWISS-PROTNote=Defects in BRAF are found in a wide range of cancers
    SWISS-PROTLung cancer (LNCR) [MIM:211980]: A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis. Note=The gene represented in this entry is involved in disease pathogenesis
    SWISS-PROTFamilial non-Hodgkin lymphoma (NHL) [MIM:605027]: Cancer that starts in cells of the lymph system, which is part of the body's immune system. NHLs can occur at any age and are often marked by enlarged lymph nodes, fever and weight loss. Note=The gene represented in this entry is involved in disease pathogenesis
    SWISS-PROTCardiofaciocutaneous syndrome 1 (CFC1) [MIM:115150]: A multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTNoonan syndrome 7 (NS7) [MIM:613706]: A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTLEOPARD syndrome 3 (LEOPARD3) [MIM:613707]: A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness. Note=The disease is caused by mutations affecting the gene represented in this entry

    BRAF cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene